-+ 0.00%
-+ 0.00%
-+ 0.00%

Vaxcyte reports Phase 1/2 adult data showing VAX-31 met noninferiority to Prevnar 20 and achieved ~95% IPD coverage

Reuters·03/18/2026 23:34:29

Please log in to view news